Dr. Roseanne D. Dobkin completed her PhD in clinical psychology at the Medical College of Pennsylvania-Hahnemann University (2002) and a postdoctoral fellowship in clinical psychopharmacology at Robert Wood Johnson Medical School (2003).

She has been conducting mental health research in Parkinson’s disease (PD) for the past 13 years. To date, her research has addressed the efficacy of face-to-face cognitive-behavioral treatment (CBT) for depression in PD (dPD) in a randomized controlled trial, and the development and pilot-testing of telephone-based CBT interventions for dPD. She has systematically examined barriers to mental health care utilization in PD and the use of telemedicine to leverage access to specialized mental health care in the PD community.

Dr. Dobkin is also a practicing psychologist and the mental health lead for the University of Delaware’s Parkinson’s Disease Telemedicine Clinic. Her prior work has been funded by the National Institutes of Health and the Patterson Trust Awards Program in Clinical Research.